Cargando…
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19 (COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over 21,000 deaths as of March 25, 2020. While under control in some affected Asian countries (Taiwan, Singapore, Vietnam), the virus demon...
Autores principales: | Nikolich-Zugich, Janko, Knox, Kenneth S., Rios, Carlos Tafich, Natt, Bhupinder, Bhattacharya, Deepta, Fain, Mindy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145538/ https://www.ncbi.nlm.nih.gov/pubmed/32274617 http://dx.doi.org/10.1007/s11357-020-00186-0 |
Ejemplares similares
-
Correction to: SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
por: Nikolich-Zugich, Janko, et al.
Publicado: (2020) -
T cell aging: naive but not young
por: Nikolich-Žugich, Janko
Publicado: (2005) -
Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections
por: Nikolich-Žugich, Janko
Publicado: (2008) -
Age-associated T-cell Clonal Expansions (TCE) in vivo—Implications for Pathogen Resistance
por: Nikolich-Žugich, Janko, et al.
Publicado: (2008) -
Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
por: Bime, Christian, et al.
Publicado: (2021)